CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
Open Access
- 24 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 6095
Abstract
Osteosarcoma is the most common primary tumor of the skeletal system and is well-known to have an aggressive clinical outcome and high metastatic potential. The chemokine (C-X-C motif) ligand 13 (CXCL13) plays a vital role in the development of several cancers. However, the effect of CXCL13 in the motility of osteosarcoma cells remains uncertain. Here, we found that CXCL13 increases the migration and invasion potential of three osteosarcoma cell lines. In addition, CXCL13 expression was upregulated in migration-prone MG-63 cells. Vascular cell adhesion molecule 1 (VCAM-1) siRNA and antibody demonstrated that CXCL13 promotes migration via increasing VCAM-1 production. We also show that CXCR5 receptor controls CXCL13-mediated VCAM-1 expression and cell migration. Our study identified that CXCL13/CXCR5 axis facilitate VCAM-1 production and cell migration in human osteosarcoma via the phospholipase C beta (PLCβ), protein kinase C α (PKCα), c-Src, and nuclear factor-κB (NF-κB) signaling pathways. CXCL13 and CXCR5 appear to be a novel therapeutic target in metastatic osteosarcoma.Keywords
This publication has 43 references indexed in Scilit:
- Vascular cell adhesion molecule‐1 (VCAM‐1)—An increasing insight into its role in tumorigenicity and metastasisInternational Journal of Cancer, 2014
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer CellsCancer Research, 2012
- CCL5 and CCR5 Interaction Promotes Cell Motility in Human OsteosarcomaPLOS ONE, 2012
- PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cellsMolecular Cancer, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Cyclooxygenase-2 enhances α2β1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cellsMolecular Cancer, 2010
- Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathwayJournal of Cellular Physiology, 2010
- CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathwaysBiochemical Pharmacology, 2009
- Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase Cα, c-Src, NF-kappaB and p300 pathwayMolecular Immunology, 2008
- Common Musculoskeletal Tumors of Childhood and AdolescenceNew England Journal of Medicine, 1999